Navigation Links
Food and Drug Administration Expert to Deliver Keynote Address
Date:10/13/2009

WARRENDALE, Pa., Oct. 13 /PRNewswire/ -- UBM International Media, a wholly owned subsidiary of United Business Media plc (LSE: UBM) and AIM, the international association and recognized authority on bar code, RFID, and enterprise mobile computing, today announced that the FDA's Jay Crowley, senior advisor for patient safety, Center for Devices and Radiological Health, will deliver the keynote address for the Track & Trace Virtual Trade Show on opening day, December 2nd in the online presentation theater.

Speaking about "The Upside of a Unique Device Identification (UDI) Mandate", Crowley will outline the urgent need for traceability for medical devices and what the healthcare community needs to know to be ready. Included in the address will be practical ways that the device manufacturers, healthcare providers, and patients will be affected by upcoming changes.

"Tracking and tracing the path of medical devices from manufacture, distribution, up to the point of use and possible recall, including ultimate end-of-product life, has implications of broad proportions within today's healthcare community," states Crowley. "The Virtual Trade Show provides a unique opportunity to raise awareness about the importance of unique identification and its role in improving patient safety."

The Track & Trace Virtual Trade Show is the first exclusively online exhibition and conference that uses cutting-edge technology to connect a larger community of industry professionals, decision-makers and leading suppliers from the auto ID market, in real time.

Attendee registration is complimentary and will open October 19. More information is available online at www.ubmtrackandtrace.com.

About UBM

UBM International Media is a wholly owned subsidiary of United Business Media plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, visit them online at www.unitedbusinessmedia.com.

About AIM

AIM is the industry association and worldwide authority on automatic identification and data collection technologies. AIM members are providers and users of technologies, systems, and services that capture, manage, and integrate accurate data into larger information systems.

For more information about AIM and its members and services, please visit www.aimglobal.org or www.rfid.org.

SOURCE UBM


'/>"/>
SOURCE UBM
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
2. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
3. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
4. Regence to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season
5. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
6. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
7. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
8. Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
9. ISTA Pharmaceuticals New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
10. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
11. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... -- Research and Markets has announced the addition ... Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and ... ... Market Sales Volume, Company Analysis and Forecast to 2022 provides ... The growing prevalence of hearing impairment coupled with ...
(Date:1/20/2017)... BUFFALO, N.Y. , Jan. 20, 2017 /PRNewswire/ ... health programs, has announced the launch of an ... to new guidelines on opioids and helps stem ... Opioids are often prescribed to treat chronic non-cancer ... disease) despite serious risks and lack of evidence ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery Devices ... the Germany Cataract Surgery Devices market. The report provides ... and average prices (USD) within market segements - Phacoemulsification ... also provides company shares and distribution shares data for ...
Breaking Medicine Technology:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located in ... the growing demand of physicians and patients throughout the United States for high-quality ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... for tech innovators, engineers, and scientists from around the world, announces the launch ... users a quick and easy portal to research breakthroughs and trending news, vital ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic surgery ... order to make it easier for their readers to get the information they desire. ... as well as the techniques used on those particular areas. , “We are excited ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... dermatologist by the American Board of Dermatology and fellowship trained Mohs and cosmetic ... National Institutes of Health, Dr. Li completed his internship in internal medicine at ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... a doctor who administered fillers that resulted in severe facial disfiguration. After four ... taken on by doctors at UCLA Medical Center, who removed the substances in ...
Breaking Medicine News(10 mins):